Increased Distributions Declared by Destra Multi-Alternative Fund
MWN-AI** Summary
The Destra Multi-Alternative Fund (DMA), traded on the NYSE, has announced an increase in its monthly distributions, starting from December 2025 through September 2026. The fund's Board of Trustees has approved a distribution rate of $0.1125 per share for each month, representing a significant increase of $0.02 per share, or 21.6%, over the previous rate of $0.0925 per share for October and November 2025.
This new distribution rate equates to an annualized return of approximately 13.21% calculated on the net asset value (NAV) as of December 5, 2025, and an annualized return of around 15.46% based on the market closing price on the same date. Robert A. Watson, President of the Fund, expressed satisfaction with the ongoing transformation of the portfolio, crediting the positive performance of Validex in supporting these distributions.
Mark Scalzo, Portfolio Manager and CIO of Validex Global Investing, the Fund's Sub-Adviser, noted that the fund is continuing to shift towards more liquid hedged strategies using the Validex Dynamic Alpha process, yielding favorable outcomes.
The Destra Multi-Alternative Fund offers a Dividend Reinvestment Plan (DRP), allowing shareholders to reinvest dividends instead of receiving cash payments, unless they opt out. It is essential for shareholders to consult their tax advisers regarding the tax implications of these distributions, as portions may come from sources other than net investment income, like capital gains or return of capital.
The Fund aims for long-term performance that is not correlated with traditional stock and bond markets, focusing on alternative strategies and asset classes. For more information, shareholders can visit Destra Capital's website or reach out to their support services.
MWN-AI** Analysis
The Destra Multi-Alternative Fund (DMA) has recently announced a significant increase in its monthly distributions, raising the rate to $0.1125 per share from the previous $0.0925. This 21.6% hike reflects strong performance and a strategic shift towards more liquid hedged strategies as part of the Fund's ongoing transformation.
For investors, this move is a positive signal, indicative of the Fund's robust portfolio management and the effectiveness of its Validex Dynamic Alpha strategy. The new distribution translates to a compelling annualized yield of approximately 15.46% based on the recent market price of $8.73, presenting an attractive income opportunity for income-focused investors.
With the ability to reinvest dividends through a Dividend Reinvestment Plan (DRP), shareholders should consider participating to enhance their total returns over time. Reinvesting dividends can lead to the power of compounding returns, particularly in an environment where alternative investments may offer less correlation to traditional asset classes.
However, caution is warranted; a portion of the distributions may derive from sources other than net investment income, including capital gains or return of capital. Therefore, investors should stay informed about the tax implications associated with these distributions, as they will receive a Form 1099-DIV at year-end to report income properly.
In summary, the increased distributions and strategic portfolio adjustments highlight the Destra Multi-Alternative Fund's commitment to generating value for shareholders. Investors looking for alternative investment opportunities could find value in DMA, particularly those prioritizing income alongside diversification. As always, investors should conduct their analysis and consider their financial situations when making investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
The Destra Multi-Alternative Fund (the “Fund” or “DMA”), a closed-end fund traded on the New York Stock Exchange under the symbol DMA, is pleased to announce that its Board of Trustees have approved distributions for December 2025 through September 2026. The rate has been declared at $0.1125 per share in each month.
| Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | |
| DMA | ||||||||||
| Pay Date | 12/30/2025 | 1/30/2026 | 2/27/2026 | 3/31/2026 | 4/30/2026 | 5/29/2026 | 6/30/2026 | 7/31/2026 | 8/31/2026 | 9/30/2026 |
| Record Date | 12/19/2025 | 1/19/2026 | 2/17/2026 | 3/20/2025 | 4/20/2026 | 5/19/2026 | 6/19/2026 | 7/21/2026 | 8/21/2026 | 9/18/2026 |
“We are pleased with the continued portfolio transformation and the performance that Validex has delivered to support the monthly distributions,” said, Robert A. Watson, CFP®, President of the Fund. The distribution rate of $0.1125 per share, which the Board has approved for the next ten months, represents a $0.02 per share or 21.6% increase over the previous October and November 2025 distributions of $0.0925 per share. The new distribution reflects a ~13.21% annualized rate at the NAV as of December 5, 2025 of $10.22 per share and corresponds to a ~15.46% annualized rate at the closing MKT price on the same date of $8.73”.
“We continue to transition more of the portfolio into liquid hedged strategies, utilizing our Validex Dynamic Alpha process and it has generated encouraging results,” said Mark Scalzo, Portfolio Manager and CIO of Validex Global Investing, the Fund’s Sub-Adviser.
The Fund offers a Dividend Reinvestment Plan (“DRP”). Shareholders who hold their shares at a broker dealer and would like to participate in the DRP should contact their broker dealer to set their reinvestment preferences. Shareholders who hold their shares directly with the Fund will have all dividends declared on the shares automatically reinvested in additional shares by the Fund’s plan agent, Equiniti Trust Company, LLC (“EQ”), unless the shareholder elects otherwise by contacting EQ. Shareholders who elect not to participate in the DRP will receive all dividends and other distributions in cash, paid by check and mailed directly to the shareholder of record. Shareholders may obtain more information on the shareholder services offered to the Fund by calling EQ at the Fund’s dedicated toll free number 800-591-8238.
A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain, or return of capital. As required by Section 19(a) of the Investment Company Act of 1940 and Rule 19a-1 thereunder, a notice will be distributed to shareholders in the event that a portion of a monthly distribution is derived from sources other than undistributed net investment income. The final determination of the source and tax characteristics of these distributions will depend upon the Fund’s investment experience during its fiscal year and will be made after the Fund’s fiscal year end. The Fund will send shareholders a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes, but shareholders should consult their own tax advisers regarding their specific tax situations and to obtain a complete understanding of the tax consequences. For further information regarding the Fund’s distributions, please visit www.destracapital.com .
About Destra Multi-Alternative Fund
Destra Multi-Alternative Fund (NYSE: DMA) is a core alternative solution that seeks to achieve long-term performance non-correlated to the broad stock and bond markets. It invests primarily in alternative strategies and asset classes centered on the Validex Dynamic Alpha hedged equity process, which is further diversified by allocations to direct private equity and alternative income sub-categories like real estate & alternative credit.
About Destra Capital Advisors
Destra Capital Advisors LLC, based in Bozeman, MT, serves as Investment Adviser and Secondary Market Servicing agent to the Fund. Validus Growth Investors LLC (dba Validex Global Investing) serves as the Investment Sub-Adviser to the Fund.
Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.
Information regarding the Fund and Destra Capital Advisors can be found at www.destracapital.com
About Validex Global Investing
Validex Global Investing seeks growth at the edge of inflection. Their proprietary research aims to identify emergent turning points as they unfold, pairing high-conviction opportunities with sophisticated risk-mitigation strategies across both private and public markets.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251209776363/en/
Please contact Destra Capital Advisors LLC, the Fund’s marketing, and investor support services agent, at DMA@destracapital.com or call (877) 855-3434 if you have any questions regarding DMA.
FAQ**
What factors contributed to the recent increase in the monthly distribution rate for the Destra Multi-Alternative Fund DMA, from $0.0925 to $0.1125 per share?
How does the portfolio transformation and strategies employed by Validex Global Investing enhance performance for investors in the Destra Multi-Alternative Fund DMA?
What are the tax implications for shareholders receiving distributions from the Destra Multi-Alternative Fund DMA, especially with regards to potential return of capital or short-term gains?
Can you explain the benefits of participating in the Dividend Reinvestment Plan (DRP) for shareholders of the Destra Multi-Alternative Fund DMA compared to receiving cash distributions?
**MWN-AI FAQ is based on asking OpenAI questions about Destra Multi-Alternative Fund (NYSE: DMA).
NASDAQ: DMA
DMA Trading
0.98% G/L:
$8.28 Last:
6,989 Volume:
$8.34 Open:
